Physician

Linda J Moore, MD

According to 2025 Medicare claims, Linda Moore, MD (NPI: 1134116106) practices family practice in the Columbus, GA-AL market, with the plurality of this provider's patient population coming from Muscogee, GA. This provider's primary affiliated billing organization is CONCIERGE MEDICINE OF COLUMBUS, INC (NPI: 1679089296; TIN: 823250547) and primary practice location at 31904-9245. Moore is affiliated with the Piedmont Clinic ACO LLC (ACO ID: A3250), participating under the MSSP model.

Moore's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,393 traditional Medicare patients, billed 50,631 HCPCS/CPT codes, and received $359,433 in Medicare payments. The top billing code was 84443 (Blood test, thyroid stimulating hormone (tsh)). Part D data shows 3,656 prescription claims across 218 beneficiaries totaling $468,223 in drug costs, led by Farxiga (Dapagliflozin Propanediol). 2022 DME data shows 33 claims. Open Payments data shows 43 records totaling $927. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $83,831 to $359,433. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $822,090 to $468,223. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $26,538 to $5,518.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	608	1,900	$83,831
2016	514	1,893	$76,619
2017	627	1,449	$52,269
2018	285	716	$30,483
2019	426	2,176	$74,806
2020	818	10,442	$154,494
2021	1,060	14,915	$228,794
2022	1,048	27,500	$239,843
2023	1,299	50,118	$335,579
2024	1,393	50,631	$359,433

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	586	12,801	$822,090
2016	627	13,374	$949,454
2017	645	10,094	$871,243
2018	516	2,318	$191,106
2019	120	1,744	$119,714
2020	140	2,098	$184,654
2021	150	2,453	$262,114
2022	184	2,944	$312,744
2023	226	3,708	$441,760
2024	218	3,656	$468,223

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	137	506	$15,848
2016	141	461	$9,021
2017	68	323	$6,286
2018	12	121	$2,501
2019	N/R	41	$662
2020	N/R	87	$3,675
2021	N/R	42	$2,750
2022	N/R	33	$334
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
84443	Blood test, thyroid stimulating hormone (tsh)	1,104	1,587	$16
80061	Blood test, lipids (cholesterol and triglycerides)	1,245	2,157	$13
36415	Insertion of needle into vein for collection of blood sample	1,350	3,000	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	943	1,805	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	1,219	1,915	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	64	2,682	$50,243
Eliquis	Apixaban	72	2,547	$49,163
Trulicity	Dulaglutide	35	1,204	$41,078
Ozempic	Semaglutide	13	770	$25,116
Jardiance	Empagliflozin	19	990	$18,641

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$927	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Linda J. Moore, MD?

Tedicare shows public-source Medicare data for Linda J. Moore, MD (NPI 1134116106), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Linda J. Moore, MD have ACO affiliation data?

Linda J. Moore, MD is shown with ACO affiliation data for Piedmont Clinic ACO LLC (MSSP, ACO ID A3250).

What billing organization is linked to Linda J. Moore, MD?

Linda J. Moore, MD is linked to CONCIERGE MEDICINE OF COLUMBUS, INC (billing NPI 1679089296) in the available physician profile data.

Does Linda J. Moore, MD have Open Payments data?

Linda J. Moore, MD has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.